Cascala Health, a healthcare technology company specializing in AI solutions for care teams and post-acute care operators, has raised $8.6 million in seed financing. The funding round was co-led by Flare Capital Partners and Eniac Ventures, along with contributions from other investors, bringing total funding to $11.23 million since its launch in mid-2024.
The funds will be used to accelerate product development and expand clinical intelligence capabilities, meeting the growing market demand. Cascala addresses significant care transition and staffing gaps in the healthcare system, which can result in billions of dollars in costs and negatively impact patient outcomes.
Founded in early 2024 with support from Redesign Health and Flare Capital Partners, Cascala’s AI platform integrates real-time insights into clinicians’ workflows, enhancing decision-making for the management of chronic diseases and care transitions. Key features include Clarity for data curation and Continuity for patient views, and it integrates with any web-based EMR or population health platform.
Cascala’s solution is designed for skilled nursing and home health operators, improving documentation, workflows, and personalized interventions. Currently deployed with over 1,000 facilities, it supports more than 300,000 patients, helping customers reduce administrative workloads. With backing from Ziegler Link-age Fund and Omega Healthcare, Cascala aims to expand its impact, closing care gaps and improving clinical and financial performance.
KEY QUOTES:
“This financing marks a pivotal milestone for Cascala. With the combined backing of leading institutional investors – and new strategic partners Ziegler Link•age Fund and Omega Healthcare – we will accelerate our delivery of clinically responsible, real-time AI that empowers care teams and skilled nursing operators to close critical gaps, reduce avoidable readmissions and drive durable value across the post-acute continuum.”
Matt A. Murphy, CEO and Co-Founder of Cascala Health
“As one of Matt’s early supporters from his time as a Flare Scholar, we recognized his exceptional ability to identify critical healthcare challenges and build innovative solutions. We’re delighted to strengthen our partnership with Cascala Health as they address a significant gap in value-based care delivery by combining explainable AI with seamless workflow integration, uniquely positioning the company to transform care transitions at scale.”
Victor Lanio, Partner at Flare Capital Partners
“Skilled nursing operators have long faced the dual challenge of rising patient acuity and margin pressure – both of which can be mitigated by ‘smart’ admissions. Cascala Health is delivering a purpose-built solution that integrates actionable clinical and financial intelligence directly into care transition workflows. By doing so, it helps post-acute organizations optimize reimbursement, streamline operations, and empower their teams to deliver high-quality care. We’re excited to support a company that understands the complex realities of post-acute care and is building technology that meets the moment.”
Katie Schmitz, Managing Partner of the Ziegler Link-age Fund
“The fragmentation in care transitions costs our healthcare system billions annually while compromising patient care. Cascala’s approach of combining AI-enabled intelligence with practical workflow solutions has demonstrated impressive early results. We’re excited to support their mission to transform this critical aspect of healthcare delivery.”
Timothy Young, Founding General Partner at Eniac Ventures
